RT Journal Article
SR Electronic
T1 Assessing our capability to predict the presence of respiratory diseases at the age of four using data available at one month of age
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.04.21259873
DO 10.1101/2021.07.04.21259873
A1 Xinyi Han
A1 Lawrence E. K. Gray
A1 Robert K. Mahar
A1 John B. Carlin
A1 Sarath Ranganathan
A1 Peter J. Vuillermin
A1 Damjan Vukcevic
YR 2021
UL http://medrxiv.org/content/early/2021/07/05/2021.07.04.21259873.abstract
AB Chronic respiratory diseases are often difficult to cure and are likely to originate early in life. Therefore, early identification of such diseases is of interest for early prevention.We explored the potential to predict these almost from birth; using data at 1 month of age, we attempted to predict disease occurrence 4 years later in life. Our data came from the Barwon Infant Study; after cleaning and processing, we had measurements on 41 variables from 401 participants.We considered three respiratory diseases: asthma, wheeze and hay fever. As predictors, we used a variety of information that would be available in a clinical setting. Of particular interest to our investigation was whether lung function measurements (newly available at such an early age) would helpfully improve predictive accuracy. We also investigated whether maternal smoking (previously associated with respiratory illnesses) is a helpful predictor.Our methods included logistic regression as the main model, multiple imputation to deal with missing values, stepwise selection and LASSO to select variables, and cross-validation to assess performance. We measured predictive performance using AUC (area under the receiver operating characteristic curve), sensitivity and specificity.Broadly, we found that the best models had only modest predictive power for each disease. For example, for asthma we achieved an AUC of 0.67, a sensitivity of 68% and a corresponding specificity of 63%. Performance for the other two diseases was similar.We also found that our lung function measurements did not improve predictive performance; some-what surprisingly, this was also true for maternal smoking. The most useful predictors included, among others, family history of these diseases and variables relating to the size of the infants.Given the modest performance of these models, our findings suggest that very early prediction of respiratory illnesses is still a challenging task.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe establishment and infrastructure for the Barwon Infant Study was funded by the Murdoch Children's Research Institute, Deakin University, and Barwon Health. Subsequent funding was provided by the National Health and Medical Research Council (NHMRC; grants APP607370, APP1009044, APP1029927, APP1024619, APP1030701, APP1076667, APP1147970); the Shepherd Foundation; the Jack Brockhoff Foundation; the Scobie Trust; the Shane O'Brien Memorial Asthma Foundation; the Our Women's Our Children's Fundraising Committee Barwon Health; the Rotary Club of Geelong; the Ilhan Food Allergy Foundation; Geelong Medical and Hospital Benefits Association; the Percy Baxter Charitable Trust; Perpetual Trustees; and Vanguard Investments Australia. In-kind support was provided by the Cotton On Foundation and CreativeForce. Research at the Murdoch Children's Research Institute is supported by the Victorian Government through the Operational Infrastructure Support Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Barwon Health HRECAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFor queries about the data, please contact the Barwon Infant Study at BIS@BarwonHealth.org.au